MX2010001533A - Composicion terapeutica aromatizada a base de argilo. - Google Patents

Composicion terapeutica aromatizada a base de argilo.

Info

Publication number
MX2010001533A
MX2010001533A MX2010001533A MX2010001533A MX2010001533A MX 2010001533 A MX2010001533 A MX 2010001533A MX 2010001533 A MX2010001533 A MX 2010001533A MX 2010001533 A MX2010001533 A MX 2010001533A MX 2010001533 A MX2010001533 A MX 2010001533A
Authority
MX
Mexico
Prior art keywords
clay
flavoured
therapeutic composition
based therapeutic
flavour
Prior art date
Application number
MX2010001533A
Other languages
English (en)
Inventor
Jerome Barra
Denis Le Hazif
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of MX2010001533A publication Critical patent/MX2010001533A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)

Abstract

La presente invención tiene por objeto una composición terapéutica aromatizada que contiene un argilo como principio activo, y caracterizada porque el argilo es una esmectita dioctaédrica y el aroma está encapsulado.
MX2010001533A 2007-08-13 2008-08-12 Composicion terapeutica aromatizada a base de argilo. MX2010001533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
PCT/FR2008/001185 WO2009056703A1 (fr) 2007-08-13 2008-08-12 Composition thérapeutique aromatisée à base d'argile

Publications (1)

Publication Number Publication Date
MX2010001533A true MX2010001533A (es) 2010-03-15

Family

ID=39052728

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001533A MX2010001533A (es) 2007-08-13 2008-08-12 Composicion terapeutica aromatizada a base de argilo.

Country Status (27)

Country Link
US (2) US20100159013A1 (es)
EP (3) EP2025332A1 (es)
JP (2) JP5670189B2 (es)
KR (2) KR101503957B1 (es)
CN (2) CN101778622A (es)
AR (2) AR067929A1 (es)
BR (1) BRPI0814979A2 (es)
CA (1) CA2696062C (es)
CL (1) CL2008002366A1 (es)
DK (1) DK2194968T3 (es)
EA (1) EA017118B1 (es)
ES (2) ES2582871T3 (es)
GE (1) GEP20125539B (es)
HK (2) HK1143956A1 (es)
HU (1) HUE029713T2 (es)
MA (1) MA31678B1 (es)
ME (1) ME00975B (es)
MX (1) MX2010001533A (es)
NO (1) NO20100114L (es)
PE (1) PE20090939A1 (es)
PL (2) PL2710998T3 (es)
PT (2) PT2194968E (es)
SA (1) SA08290496B1 (es)
TN (1) TN2010000058A1 (es)
TW (2) TWI511734B (es)
UA (1) UA97408C2 (es)
WO (1) WO2009056703A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
JP2014503552A (ja) 2011-01-12 2014-02-13 ソーフト イタリア エスピーエー 円錐角膜の処置のためのイオン導入による架橋剤の角膜送達および関連眼科組成物
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190202A4 (en) * 1984-07-16 1987-01-22 Sunkist Growers Inc SOLID FRAGRANCE COMPOSITION FOR ESSENTIAL OILS AND THEIR PRODUCTION.
US4707367A (en) 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
EP1123660A3 (en) * 1993-04-16 2004-01-07 McCORMICK & COMPANY, INC. Encapsulation compositions
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
AR114148A2 (es) 2020-07-29
KR20140133617A (ko) 2014-11-19
JP2014208715A (ja) 2014-11-06
EP2194968A1 (fr) 2010-06-16
AR067929A1 (es) 2009-10-28
PL2710998T3 (pl) 2016-11-30
DK2194968T3 (da) 2013-09-02
ES2582871T3 (es) 2016-09-15
CL2008002366A1 (es) 2009-05-29
EA201070257A1 (ru) 2010-06-30
CN104173371A (zh) 2014-12-03
EP2710998A1 (fr) 2014-03-26
ES2421379T3 (es) 2013-09-02
PL2194968T3 (pl) 2013-10-31
SA08290496B1 (ar) 2012-11-03
WO2009056703A1 (fr) 2009-05-07
PT2194968E (pt) 2013-07-25
HK1196271A1 (zh) 2014-12-12
TW200914034A (en) 2009-04-01
TWI519303B (zh) 2016-02-01
GEP20125539B (en) 2012-05-25
CN101778622A (zh) 2010-07-14
JP5670189B2 (ja) 2015-02-18
MA31678B1 (fr) 2010-09-01
US20140377354A1 (en) 2014-12-25
HUE029713T2 (en) 2017-03-28
TW201509424A (zh) 2015-03-16
CA2696062C (fr) 2017-09-05
EA017118B1 (ru) 2012-09-28
ME00975B (me) 2012-06-20
PT2710998T (pt) 2016-07-28
EP2025332A1 (fr) 2009-02-18
NO20100114L (no) 2010-03-10
WO2009056703A8 (fr) 2010-03-04
US9056055B2 (en) 2015-06-16
KR101503957B1 (ko) 2015-03-18
TWI511734B (zh) 2015-12-11
PE20090939A1 (es) 2009-07-27
TN2010000058A1 (fr) 2011-09-26
JP2010535852A (ja) 2010-11-25
HK1143956A1 (en) 2011-01-21
KR20100055460A (ko) 2010-05-26
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
US20100159013A1 (en) 2010-06-24
BRPI0814979A2 (pt) 2015-02-03
UA97408C2 (ru) 2012-02-10
EP2194968B1 (fr) 2013-06-19

Similar Documents

Publication Publication Date Title
MX2010002285A (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas.
WO2007045252A3 (en) An edible composition
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2008128115A3 (en) Low-dose doxepin formulations
DE602006002260D1 (de) Insektenabweisende zusammensetzungen mit verzögerter freisetzung
AR114148A2 (es) Composición terapéutica saborizada basada en arcilla
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
WO2006116349A3 (en) Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
GB2443793B (en) Product, method of manufacture and use
EP2338496A4 (en) AGENT FOR PROMOTING HAIR GROWTH CONTAINING A 15,15-DIFLUOROPROSTAGLANDINE F2alpha DERIVATIVE AS ACTIVE INGREDIENT
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
MX2009013708A (es) Uso de derivados de acido tetramico para combatir vectores transmisores de virus.
WO2006042625A3 (de) Zusammensetzungen mit inhibitoren der prostaglandin-und/oder leukotrien-synthese in kombination mit stimulatoren der freisetzung kutaren neuromediatoren
MX2009006777A (es) Combinaciones de principios activos sinergicas.
TW200628168A (en) Use of organic compounds
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
HK1111924A1 (en) Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient
ZA201005394B (en) 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid y-lactone derivative,use thereof,and medicament containing said derivative
WO2007014671A3 (de) KOMBINATIONEN MIT IKK-ß INHIBITOREN
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
MX2009001217A (es) Helado y formulaciones para helado que contienen maltitol.
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent

Legal Events

Date Code Title Description
FG Grant or registration